Results

Total Results: 1,166 records

Showing results for "loss".

141. Primary Care Management of Abnormal Uterine Bleeding (AUB) | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/abnormal-uterine-bleeding/research-protocol
     November 21, 2011 - cycle-to-cycle variation) within ± 2 to 20 days Duration of flow from 4 to 8 days Volume of blood loss … Tranexamic acid appears to be well-tolerated and cost-effective, reducing blood loss considerably and … the LNG IUS provided clinically and statistically significant sustained reductions in menstrual blood loss … of outcome, adequate duration of followup, and adequate followup of the cohort (i.e., reporting of loss … Menstrual blood loss--a population study.

142. Disposition of Comments Report for Evaluation and Treatment of Tinnitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/tinnitus_disposition-comments.pdf
     August 23, 2013 - as Psychological/Behavioral do not preclude the use of technology; e.g., individuals with hearing loss … as Psychological/Behavioral do not preclude the use of technology; e.g., individuals with hearing loss … as Psychological/Behavioral do not preclude the use of technology; e.g., individuals with hearing loss … We have provided references to support the statement that tinnitus (and hearing loss) increase with … I don’t feel that the association between hearing loss and tinnitus in younger people was explored in

143. Abnormal-Uterine-Bleeding Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/abnormal-uterine-bleeding_research-protocol.pdf
     November 21, 2011 - cycle-to-cycle variation) within ± 2 to 20 days  Duration of flow from 4 to 8 days  Volume of blood loss … Tranexamic acid appears to be well-tolerated and cost- effective, reducing blood loss considerably and … LNG IUS provided clinically and statistically significant sustained reductions in menstrual blood loss … and complementary and alternative medicine (CAM) interventions (e.g., hormonal treatment, weight loss … Menstrual blood loss--a population study.

144. Effectiveness of Treatments for Diabetic Peripheral Neuropathy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetic-neuropathy_research-protocol.pdf
     May 09, 2016 - The signs of diabetic peripheral neuropathy are loss of vibratory sensation and altered proprioception … caused by large-fiber loss, and impairment of pain, light touch, and temperature caused by loss of … DPN is usually described as glove-stocking distribution of numbness, sensory loss, paresthesia (abnormal … Sensory loss from neuropathy increases risk for foot injury, delayed treatment (since injuries are not … ulcers § Lifestyle interventions (carbohydrate-controlled diet aimed at glucose reduction, weight loss

145. Critical Analysis of the Evidence for Patient Safety Practices in Nursing Home Settings (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/nursing-home-safety_research-protocol.pdf
     July 22, 2015 - infection, including hospital acquired infection (HAI) and urinary tract infection, excessive weight loss … These outcomes align with the most common reasons for NH litigation (falls, pressure ulcers, weight loss … infection, including hospital acquired infection (HAI) and urinary tract infection, excessive weight loss … training approaches to improve both NH care processes and outcomes in the areas of unintentional weight loss … Medication management, staff education and training, health information technology Excessive weight loss

146. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - of 4 kg at 39 weeks, compared with a 2 kg weight loss in the placebo group. … Weight loss over 39 weeks depended on drug dose. … , but this treatment cannot reverse vision loss that has already occurred. … Weight loss surgery. Policy number G001-19. [internet]. … The bariatric management program for weight loss surgery. [internet].

147. Quantitative Synthesis II: Interactive Quiz (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/selecting-evidence-quiz.ppt
     September 02, 2013 - Attrition bias refers to systematic differences among comparison groups in the loss of participants from … the study and their loss of being accounted for in results.

148. Quantitative Synthesis II: Interactive Quiz (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/selecting-evidence-quiz.ppt
     September 02, 2013 - Attrition bias refers to systematic differences among comparison groups in the loss of participants from … the study and their loss of being accounted for in results.

149. Glaucoma-Treatment-Appendices-11-5-10-2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment-appendices-11-5-10-2.pdf
     October 27, 2009 - hypokalemia, hyponatremia, metabolic acidosis • Osteomalacia with long-term phenytoin therapy • Loss … • Dizziness • Vertigo • Headaches • Depression • Hives • toxic epidermal necrolysis • hair loss … • confusion, • hallucinations • anxiety • disorientation, nervousness • Memory loss. … including depression, confusion, hallucinations, anxiety, disorientation, nervousness, and memory loss … Open Angle Glaucoma A progressive optic neuropathy characterized by loss of retinal ganglion cells and

150. Topic Suggestion Description | Effective Health Care Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/management-vestibular-schwannomas
     June 11, 2021 - MRI to evaluate patients with previously published definitions of asymmetric sensorineural hearing loss … for vestibular schwannomas when using an MRI to evaluate patients with a sudden sensorineural hearing loss

151. Assessing Applicability: Interactive Case Study Quiz (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/assessing-applicability-quiz.ppt
     September 02, 2013 - the use of a new medication in male astronauts, 25 to 35 years of age, prevents bone mineral density loss … the use of a new medication in male astronauts, 25 to 35 years of age, prevents bone mineral density loss

152. Assessing Applicability: Interactive Case Study Quiz (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/assessing-applicability-quiz.ppt
     September 02, 2013 - the use of a new medication in male astronauts, 25 to 35 years of age, prevents bone mineral density loss … the use of a new medication in male astronauts, 25 to 35 years of age, prevents bone mineral density loss

153. Treating and Preventing C. difficile Infections (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-difficile-update_consumer.pdf
     May 01, 2017 - belly � A fever � Nausea � Vomiting � Not enough water in your body (called “dehydration”) � Loss … of appetite � Weight loss Anyone can get CDI, but some people have a higher risk. … Metronidazole (Flagyl®) ��Nausea ��Diarrhea ��Vomiting ��Pain in the belly ��Headache ��Constipation ��Loss

154. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes_hi_impact.pdf
     March 01, 2012 - Several experts noted that subcutaneous exenatide use would also result in effective weight loss. … They may also help promote weight loss in overweight and obese patients. … However, one clinical expert expressed skepticism of SGLT2’s purported ability to cause weight loss … ASMBS 2009: gastric banding achieves sustained weight loss, improvement of diabetes. … FDA expands use of banding system for weight loss. [internet]. Silver Spring (MD): U.S.

155. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes_hi_impact.pdf
     March 01, 2012 - Several experts noted that subcutaneous exenatide use would also result in effective weight loss. … They may also help promote weight loss in overweight and obese patients. … However, one clinical expert expressed skepticism of SGLT2’s purported ability to cause weight loss … ASMBS 2009: gastric banding achieves sustained weight loss, improvement of diabetes. … FDA expands use of banding system for weight loss. [internet]. Silver Spring (MD): U.S.

156. App-D-Opioid-Chronic-Pain-Surveillance-Report-3 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-3.xlsx
     September 30, 2015 - non-users (880) NR Review of electronic medical records, ICD-9 CM codes Enrolled: 1,320 Analyzed: 1,320 Loss … vs. 125.51 (SD 103.08) vs. 103.46 (SD 76.49) ICD-9 and ICD-10 codes Enrolled: 14,596 Analyzed: 4,191 Loss … ranges: 70% to 72.9% Adverse events identified from diagnosis codes Enrolled: 77,697 Analyzed: 77,697 Loss … 90-day period Diagnosis of adverse events using CPT and/or ICD codes Enrolled: 4,622 Analyzed: 4,622 Loss … any one of the rounds C) No use: no opioid use reported in any rounds Enrolled: 4,172 Analyzed: 4,172 Loss

157. A Pilot Study Using Machine Learning and Domain Knowledge To Facilitate Comparative Effectiveness Review Updating | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/machine-learning/research
     September 07, 2012 - for all relevant efficacy/effectiveness and AE articles by more than 50 percent with minimal or no loss

158. Evaluation of Effectiveness and Safety of Antiepileptic Medications in Patients with Epilepsy | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/epilepsy-medicine/research-protocol
     July 01, 2010 - termed absence seizures if they are characterized by sudden, brief lapses of consciousness without loss … Generalized seizures are termed atonic seizures if sudden loss and then regaining of postural muscle … of drivers license, and loss of employment? … Hypotension Harms specific to that particular antiepileptic medication Hospital stay duration Loss … of drivers license Loss of employment Rates of switching from generic back to innovator medication

159. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
     January 01, 2016 - Subcutaneously released long-term exenatide use could also result in effective weight loss, several … some patients experience permanent vision loss even after intensive treatment. … or completely prevents vision loss from worsening. … some patients experience permanent vision loss even after intensive treatment. … New drug for diabetes-related vision loss. [internet].

160. Screening for Glaucoma: Comparative Effectiveness | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/glaucoma-screening/research
     April 12, 2012 - study that provided evidence for direct or indirect links between glaucoma screening and visual field loss